This inventor holds 1 USPTO granted patent. Top assignee: Lanzhou University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ruyun Ma: Innovator in Medicinal Applications of Trans-1,3-Dilinolein
Introduction
Ruyun Ma is a notable inventor based in Lanzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the application of trans-1,3-dilinolein for treating gastric cancer. His innovative work has the potential to impact health products and food formulations.
Latest Patents
Ruyun Ma holds a patent titled "Application of trans-1,3-dilinolein in the preparation of medicaments for treating gastric cancer, stomachic tonic, health products and foods." This patent outlines new uses of trans-1,3-dilinolein as both a medicament and a food additive. The research indicates that trans-1,3-dilinolein promotes the proliferation of human gastric mucosal epithelial cells under various conditions and exhibits a concentration-dependent killing effect on gastric cancer cells. Notably, at concentrations of 300 µm and above, trans-1,3-dilinolein significantly kills gastric cancer cells, with enhanced effects observed under hypoxic conditions.
Career Highlights
Ruyun Ma is affiliated with Lanzhou University, where he conducts his research and development activities. His work is characterized by a strong focus on the medicinal applications of natural compounds, contributing to advancements in cancer treatment and health products.
Collaborations
Ruyun Ma collaborates with esteemed colleagues, including Zheng Jin and Yanning Zhu. Their combined expertise enhances the research outcomes and broadens the scope of their innovative projects.
Conclusion
Ruyun Ma's contributions to the field of medicinal chemistry, particularly through his patent on trans-1,3-dilinolein, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for practical applications in healthcare and nutrition.